Category

Daily Briefs

Daily Brief Financials: Vingroup Jsc, FnGuide Inc, Canara Bank and more

By | Daily Briefs, Financials

In today’s briefing:

  • MarketVector Vietnam Local Index Rebalance: One Add, Capping & Float Changes
  • Korea Small Cap Gem #36: FnGuide [Increasing Moat for Its Index Business]
  • Relative Value Roundup: Performance Recap of Financial Pair Trades


MarketVector Vietnam Local Index Rebalance: One Add, Capping & Float Changes

By Brian Freitas

  • BAF Viet Nam Agriculture JSC (BAF VN) will be added to the MarketVector Vietnam Local Index at the close on 20 June.
  • Estimated one-way turnover is 9% and that results in a round-trip trade of US$74m. There are 5 stocks with more than 1x ADV to trade from passives.
  • Vingroup Jsc (VIC VN) and Vinhomes (VHM VN) stock prices have soared over the last few months and capping results in selling at this rebalance.

Korea Small Cap Gem #36: FnGuide [Increasing Moat for Its Index Business]

By Douglas Kim

  • FnGuide has been able to capitalize on its excellent brand name in the financial industry (especially for research used in equity trading) to profitably expand into the index development business.
  • Although the index business accounted for 25% of its sales in 2024, it has been the fastest growing business in the past six years. 
  • Valuations are reasonable and it is trading at 27% below four year historical EV/EBITDA basis. We like FnGuide as a long-term investment story. 

Relative Value Roundup: Performance Recap of Financial Pair Trades

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlight: Two pair trade opportunities in the Indian financial sector persist, with price ratios exceeding two standard deviations from their historical means.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Genesis Minerals, IperionX Limited and more

By | Australia, Daily Briefs

In today’s briefing:

  • MV Australia Resources Index Rebalance: Two Adds, Float & Capping Changes
  • MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: One Add, One Delete & Other Changes


MV Australia Resources Index Rebalance: Two Adds, Float & Capping Changes

By Brian Freitas


MV Global Rare Earth/​​​​​Strategic Metals Index Rebalance: One Add, One Delete & Other Changes

By Brian Freitas


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Sun Pharmaceutical Industries, Wuxi Biologics, Genesis Healthcare, Medtronic Plc and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Sun Pharmaceutical (SUNP IN): Timely Succession Plan to Augur Well for Next-Level of Growth
  • China Healthcare Weekly (Jun.15) – Outlook of GLP-1 Market, WuXi Bio’s Placement, Keymed’s Placement
  • GEN Digital Is Tapping Into Telecom & Employers—Can This Be The Biggest Driver Of Its Future Growth?
  • Medtronic Doubles Down on Innovation as Cardiovascular Tech Takes Center Stage!


Sun Pharmaceutical (SUNP IN): Timely Succession Plan to Augur Well for Next-Level of Growth

By Tina Banerjee

  • Sun Pharmaceutical Industries (SUNP IN) is appointing Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business reporting to him.
  • In another development, Richard Ascroft will be joining as CEO – North America, succeeding Abhay Gandhi. Aalok Shanghvi has been additionally entrusted with the responsibility for the North America business.
  • Succession plan and management rejig come at a time when SPIL is at an inflection point, with its India business being on a strong foothold and specialty business gaining traction.

China Healthcare Weekly (Jun.15) – Outlook of GLP-1 Market, WuXi Bio’s Placement, Keymed’s Placement

By Xinyao (Criss) Wang

  • The GLP-1 market has officially transitioned from a duopoly to a state where Tirzepatide is eating away at Semaglutide’s market share, which should be a highly valued advance signal.
  • WuXi Bio’s Placing price of HK$26.51-26.88/share is expansive if based on 2025 forecast.Obviously, WuXi Bio hopes to leverage the positive market sentiment to complete the placement at high share price
  • Keymed plans to raise about HK$854million through a top-up placement. However, reasonable valuation for Keymed is RMB5-10 billion. In other words, the Placing Price of HK$45.48 per Share is expensive.

GEN Digital Is Tapping Into Telecom & Employers—Can This Be The Biggest Driver Of Its Future Growth?

By Baptista Research

  • Gen Digital’s latest financial results and strategic developments present a balanced picture of growth and ongoing transformation within the company.
  • During the fiscal year 2025, Gen Digital demonstrated solid financial performance, highlighted by a record revenue of nearly $4 billion, a 4% year-over-year increase, and a non GAAP operating margin of 58.4%.
  • This growth was driven by strong demand across Gen’s core cyber safety offerings, including security, privacy, and identity theft protection solutions.

Medtronic Doubles Down on Innovation as Cardiovascular Tech Takes Center Stage!

By Baptista Research

  • Medtronic’s fourth-quarter results for fiscal year 2025 demonstrated a robust finish with a reported revenue growth of 5.4%.
  • The company experienced strong performance across its cardiovascular, neuromodulation, and diabetes segments, with cardiovascular growth accelerating to 8% due to innovations in pulse field ablation and cardiac ablation solutions experiencing nearly 30% growth.
  • This momentum was further supported by double digit growth in neuromodulation and diabetes, highlighting the effectiveness of Medtronic’s innovation-centric strategy.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: HLB Inc, Guangzhou Automobile Group, Great Wall Motor, TSE Tokyo Price Index TOPIX, Foshan Haitian Flavouring & Food Company, Alibaba Group Holding , Macy’s Inc, Mitsubishi Shokuhin, Rivian Automotive , Abercrombie & Fitch Co Cl A and more

By | Consumer, Daily Briefs

In today’s briefing:

  • HLB Merger Arb’s Unique Timing Dynamics for a Juicy 8% Swap Spread
  • A/H Premium Tracker (To 13 June 2025):  HUGE H-Share Outperf Across The Board, “Beautiful Skew Move”
  • HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
  • One of the Clues to Know How Serious a Company Is About Shifting to Management that Creates Value
  • Weekly Deals Digest (15 Jun) – Haitian, Sanhua, Toyota Industries, Tryt, Fengxiang, HKBN, Mayne
  • Alibaba’s Bold AI & Cloud Bet Is Driving Our Optimism–But It Comes at A BIG COST!
  • How Macy’s Is Powering An Omnichannel Comeback With Bold Reinvestment Strategies!
  • (Mostly) Asia-Pac M&A: New World Res., Fuji Corp, TRYT, Shinsung Tongsang, Austal, Mitsu. Shokuhin
  • Rivian Just Teamed Up with Volkswagen—Can This Partnership Be a Billion-Dollar Power Move?
  • Abercrombie & Fitch Co.: An Insight into its Marketing & Digital Technology Investments & Other Major Drivers


HLB Merger Arb’s Unique Timing Dynamics for a Juicy 8% Swap Spread

By Sanghyun Park

  • Some local desks think the company pushed the timeline back to align with a potential FDA Class 1 approval for Rivoceranib expected by July.
  • No word yet if it’s Class 1 or 2; Class 2 means November decision. Despite risks, local hedge desks are building arb plays, betting on the July FDA timing dynamics.
  • No FDA decision by July means Class 2 and a sell-off, hitting HLB Co. hardest. Class 1 approval boosts both stocks, cuts cancellation risk, and sets the 8% spread floor.

A/H Premium Tracker (To 13 June 2025):  HUGE H-Share Outperf Across The Board, “Beautiful Skew Move”

By Travis Lundy

  • AH spreads are SHARPLY narrower. The effect is dramatic across the “skew” i.e. very wide AH premia contracted more than very narrow premia. BYD is on its own.
  • This smells very much like someone knows something. I expect RMB dual counters may be in the works. Caixin had an article Friday.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Monitor are both there free for SK readers.

HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big

By Travis Lundy

  • Gross SOUTHBOUND volumes up to US$15+bn a day this past 5-day week. Net buying still positive but still below US$500mm/day.
  • Among the top buys as a percentage of volume, HEALTHCARE, FINANCIALS, ENERGY stand out, dramatically. Among top sells, INFO TECH again. 9 weeks in a row negative. Tencent bigly sold.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Monitor are both there free for SK readers.

One of the Clues to Know How Serious a Company Is About Shifting to Management that Creates Value

By Aki Matsumoto

  • The driver of higher stock valuations is overseas investors, and engagement by overseas investors is likely to have a positive effect on return on capital and stock valuations.
  • In many aspects, companies seem to be unwilling to face shareholders. If they don’t confront shareholders and proceed with management reforms, they will not be able to implement serious initiatives.
  • It can be hypothesized that the behavior of prioritizing control over the AGM over engaging with shareholders provides a clue as to the seriousness of a company’s efforts.

Weekly Deals Digest (15 Jun) – Haitian, Sanhua, Toyota Industries, Tryt, Fengxiang, HKBN, Mayne

By Arun George


Alibaba’s Bold AI & Cloud Bet Is Driving Our Optimism–But It Comes at A BIG COST!

By Baptista Research

  • Alibaba Group delivered a mixed performance in the March quarter and for the full fiscal year 2025, showing resilience in its core operations while falling short of analyst expectations on key financial metrics.
  • The company reported revenue of $32.58 billion for the quarter, marking a 7% year-over-year increase, but this fell below projections of $33.28 billion.
  • Net income for the period came in at $1.71 billion, significantly lower than the anticipated $2.93 billion.

How Macy’s Is Powering An Omnichannel Comeback With Bold Reinvestment Strategies!

By Baptista Research

  • Macy’s, Inc. recently reported its first quarter 2025 financial results, showing performance that outpaced prior guidance across key metrics, yet still reflecting underlying challenges present in the retail environment.
  • The company’s net sales amounted to $4.6 billion, exceeding its forecast of $4.4 billion to $4.5 billion.
  • The comparable sales for owned, licensed, and marketplace stores showed a decline of 1.2%, which was better than the anticipated drop of 2.5% to 4.5%.

(Mostly) Asia-Pac M&A: New World Res., Fuji Corp, TRYT, Shinsung Tongsang, Austal, Mitsu. Shokuhin

By David Blennerhassett


Rivian Just Teamed Up with Volkswagen—Can This Partnership Be a Billion-Dollar Power Move?

By Baptista Research

  • Rivian Automotive reported its Q1 2025 results with several key financial and strategic developments.
  • On the financial front, Rivian achieved a notable milestone by delivering its second consecutive quarter of positive gross profit, recording $206 million, a result that secured a $1 billion investment from the Volkswagen Group.
  • This investment is expected to further support Rivian’s operational and strategic goals.

Abercrombie & Fitch Co.: An Insight into its Marketing & Digital Technology Investments & Other Major Drivers

By Baptista Research

  • Abercrombie & Fitch has reported its first-quarter results for fiscal year 2025, delivering performance that exceeded initial projections in terms of both revenue and earnings.
  • The company’s net sales reached a record $1.1 billion, marking an 8% increase compared to the previous year, exceeding the anticipated range of 4% to 6%.
  • The operating margin achieved was 9.3%, and earnings per share came in at $1.59, both surpassing initial guidance.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Hyundai Rotem Company, HLB Inc, FnGuide Inc and more

By | Daily Briefs, South Korea

In today’s briefing:

  • [Quiddity Index] MV Global Defense Jun25 Rebalance Results: Flow Expectations
  • HLB Merger Arb’s Unique Timing Dynamics for a Juicy 8% Swap Spread
  • Korea Small Cap Gem #36: FnGuide [Increasing Moat for Its Index Business]
  • MV Global Defense Industry Index Rebalance: US$1.1bn Round-Trip Trade as Stocks Soar


[Quiddity Index] MV Global Defense Jun25 Rebalance Results: Flow Expectations

By Travis Lundy

  • The MV Global Defense Industry Index represents the performance of companies in national defense industries.
  • There will be 3 ADDs for the MV Global Defense Index in June 2025. 
  • We expect one-way flow of US$505mn for June 2025, which translates to a turnover of 8.8%. 

HLB Merger Arb’s Unique Timing Dynamics for a Juicy 8% Swap Spread

By Sanghyun Park

  • Some local desks think the company pushed the timeline back to align with a potential FDA Class 1 approval for Rivoceranib expected by July.
  • No word yet if it’s Class 1 or 2; Class 2 means November decision. Despite risks, local hedge desks are building arb plays, betting on the July FDA timing dynamics.
  • No FDA decision by July means Class 2 and a sell-off, hitting HLB Co. hardest. Class 1 approval boosts both stocks, cuts cancellation risk, and sets the 8% spread floor.

Korea Small Cap Gem #36: FnGuide [Increasing Moat for Its Index Business]

By Douglas Kim

  • FnGuide has been able to capitalize on its excellent brand name in the financial industry (especially for research used in equity trading) to profitably expand into the index development business.
  • Although the index business accounted for 25% of its sales in 2024, it has been the fastest growing business in the past six years. 
  • Valuations are reasonable and it is trading at 27% below four year historical EV/EBITDA basis. We like FnGuide as a long-term investment story. 

MV Global Defense Industry Index Rebalance: US$1.1bn Round-Trip Trade as Stocks Soar

By Brian Freitas

  • Hyundai Rotem, RENK Group and Karman Holdings will be added to the MV Global Defense Industry Index after the close of trading on 20 June.
  • Constituent changes, float changes and capping changes result in an estimated one-way turnover of 8.8% and a round-trip trade of US$1.1bn.
  • The index has moved up steadily over the last few years and the ETF has taken in a big chunk of money over the last 6 months.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Guangzhou Automobile Group, Great Wall Motor, Foshan Haitian Flavouring & Food Company, Wuxi Biologics, Baidu, Alibaba Group Holding , iQIYI Inc, Cgn Mining, JD.com and more

By | China, Daily Briefs

In today’s briefing:

  • A/H Premium Tracker (To 13 June 2025):  HUGE H-Share Outperf Across The Board, “Beautiful Skew Move”
  • HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
  • Weekly Deals Digest (15 Jun) – Haitian, Sanhua, Toyota Industries, Tryt, Fengxiang, HKBN, Mayne
  • China Healthcare Weekly (Jun.15) – Outlook of GLP-1 Market, WuXi Bio’s Placement, Keymed’s Placement
  • Baidu Inc.: Dealing With The Uncertain Commercial Viability of Autonomous Driving
  • Alibaba’s Bold AI & Cloud Bet Is Driving Our Optimism–But It Comes at A BIG COST!
  • iQIYI Inc.: Growing Its Content Ecosystem & Executing Overseas Market Expansion to Help Alter The Playing Field?
  • [Quiddity Index] MV Global Uranium & Nuclear Energy Jun25 Rebalance Results: Flow Expectations
  • JD.com: AI Expansion into On-Demand Retail & Food Delivery Is An Interesting New Development!


A/H Premium Tracker (To 13 June 2025):  HUGE H-Share Outperf Across The Board, “Beautiful Skew Move”

By Travis Lundy

  • AH spreads are SHARPLY narrower. The effect is dramatic across the “skew” i.e. very wide AH premia contracted more than very narrow premia. BYD is on its own.
  • This smells very much like someone knows something. I expect RMB dual counters may be in the works. Caixin had an article Friday.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Monitor are both there free for SK readers.

HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big

By Travis Lundy

  • Gross SOUTHBOUND volumes up to US$15+bn a day this past 5-day week. Net buying still positive but still below US$500mm/day.
  • Among the top buys as a percentage of volume, HEALTHCARE, FINANCIALS, ENERGY stand out, dramatically. Among top sells, INFO TECH again. 9 weeks in a row negative. Tencent bigly sold.
  • The data tables below update on a daily basis in the Tools section of Smartkarma. The SOUTHBOUND Flow Monitor and AH Monitor are both there free for SK readers.

Weekly Deals Digest (15 Jun) – Haitian, Sanhua, Toyota Industries, Tryt, Fengxiang, HKBN, Mayne

By Arun George


China Healthcare Weekly (Jun.15) – Outlook of GLP-1 Market, WuXi Bio’s Placement, Keymed’s Placement

By Xinyao (Criss) Wang

  • The GLP-1 market has officially transitioned from a duopoly to a state where Tirzepatide is eating away at Semaglutide’s market share, which should be a highly valued advance signal.
  • WuXi Bio’s Placing price of HK$26.51-26.88/share is expansive if based on 2025 forecast.Obviously, WuXi Bio hopes to leverage the positive market sentiment to complete the placement at high share price
  • Keymed plans to raise about HK$854million through a top-up placement. However, reasonable valuation for Keymed is RMB5-10 billion. In other words, the Placing Price of HK$45.48 per Share is expensive.

Baidu Inc.: Dealing With The Uncertain Commercial Viability of Autonomous Driving

By Baptista Research

  • Baidu, Inc. delivered a solid performance in the first quarter of 2025, with its Baidu Core division reporting a 7% year-over-year revenue increase, reaching RMB 25.5 billion.
  • This growth was primarily driven by a substantial surge in its AI cloud business, which saw a 42% increase year-over-year, contributing significantly to Baidu Core’s overall revenue.
  • A notable development within this business unit is the expansion of the AI cloud’s role in Baidu’s operations, now accounting for 26% of Baidu Core’s revenue, up from 20% in the previous year.

Alibaba’s Bold AI & Cloud Bet Is Driving Our Optimism–But It Comes at A BIG COST!

By Baptista Research

  • Alibaba Group delivered a mixed performance in the March quarter and for the full fiscal year 2025, showing resilience in its core operations while falling short of analyst expectations on key financial metrics.
  • The company reported revenue of $32.58 billion for the quarter, marking a 7% year-over-year increase, but this fell below projections of $33.28 billion.
  • Net income for the period came in at $1.71 billion, significantly lower than the anticipated $2.93 billion.

iQIYI Inc.: Growing Its Content Ecosystem & Executing Overseas Market Expansion to Help Alter The Playing Field?

By Baptista Research

  • iQIYI’s first-quarter 2025 results exhibited growth across several key business segments, though certain challenges remain.
  • The company experienced sequential growth in total revenues, largely attributed to their emphasis on premium content production and strong performance in long-form and micro-dramas.
  • This focus has effectively positioned iQIYI as a leading platform for both long-form and short-form entertainment content, contributing positively to user engagement and content consumption.

[Quiddity Index] MV Global Uranium & Nuclear Energy Jun25 Rebalance Results: Flow Expectations

By Travis Lundy

  • The MV Global Uranium & Nuclear Energy index represents the performance of the biggest and the most liquid companies in the Uranium and Nuclear industries.
  • Cgn Mining (1164 HK) will be an ADD and Endesa SA (ELE SM) will be a DELETE in June 2025.
  • There are also some big capping flows so we expect a one-way flow of US$227mn for June 2025, which translates to a turnover of 15.7%.

JD.com: AI Expansion into On-Demand Retail & Food Delivery Is An Interesting New Development!

By Baptista Research

  • In the first quarter of 2025, JD.com reported strong financial and operational performance, indicating a positive start to the year.
  • The company’s total revenues increased by 16% year-over-year, showing accelerated growth compared to the previous quarter.
  • This growth was broad-based, with electronics and home appliances revenue up by 17% and general merchandise revenue rising by 15%, demonstrating the strength of JD.com’s diversified product range and supply chain capabilities.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Lam Research, Newmont , NVIDIA Corp, Palantir Technologies , Dick’s Sporting Goods, Elastic NV, C3.ai Inc, Inter Parfums, Dell Technologies , Genesis Healthcare and more

By | Daily Briefs, United States

In today’s briefing:

  • MV US Listed Semiconductor 25 Index Rebalance: US$1.2bn Round-Trip Trade
  • Newmont Corporation (NYSE: NEM) – Strong Q1, Tier 1 Growth Ahead, Significant Upside if Gold Holds
  • [Quiddity Index] MV US Semiconductor Jun25 Rebalance Results: Flow Expectations
  • Palantir’s Parabolic Surge: Meme Stock Mania Or AI Megatrend in Motion?
  • DICK’S Sporting Goods Is Betting Big on Youth Sports—and It Could Be a $40 Billion Win!
  • Elastic Ramps Up Cybersecurity Assault with Bold Security Platform Expansion!
  • C3.ai Strikes Gold with Powerhouse Partnerships—Is Big Tech Its Secret Weapon?
  • Interparfums Unveils Bold Luxury Push with New Premium Brand Additions!
  • Dell Technologies: AI Server Integration & Backlog Growth As A Pivotal Growth Lever!
  • GEN Digital Is Tapping Into Telecom & Employers—Can This Be The Biggest Driver Of Its Future Growth?


MV US Listed Semiconductor 25 Index Rebalance: US$1.2bn Round-Trip Trade

By Brian Freitas


Newmont Corporation (NYSE: NEM) – Strong Q1, Tier 1 Growth Ahead, Significant Upside if Gold Holds

By Rahul Jain

  • Recent Results: Newmont delivered a strong Q1 2025 performance with record free cash flow of $1.2 billion, driven by higher gold prices and increased production from Tier 1 assets.
  • Future Plans: The company plans to ramp up Tier 1 output to ~6.7 Moz by 2028, led by projects like Ahafo North, Tanami Expansion 2, and Cadia block-cave development.
  • Valuation Upside: If current gold prices around $3,400/oz persist, Newmont’s earnings could double vs. consensus, unlocking over 50% potential upside from current share levels.

[Quiddity Index] MV US Semiconductor Jun25 Rebalance Results: Flow Expectations

By Travis Lundy

  • The MV US Listed Semiconductor 25 index represents the performance of the biggest US-listed companies in the semiconductor industry.
  • There will be no index changes for the June 2025 rebalance event.
  • We expect a one-way flow of US$700mn for June 2025.

Palantir’s Parabolic Surge: Meme Stock Mania Or AI Megatrend in Motion?

By Baptista Research

  • Palantir Technologies has become one of Wall Street’s most polarizing success stories in 2025.
  • Riding a 76% year-to-date gain and clocking in at more than 460% over the past 12 months, the company’s stock has reached new highs, closing at a record for three consecutive sessions earlier this month.
  • The surge puts it in league with speculative darlings like CoreWeave and even evokes comparisons to meme stock veterans such as GameStop.

DICK’S Sporting Goods Is Betting Big on Youth Sports—and It Could Be a $40 Billion Win!

By Baptista Research

  • DICK’S Sporting Goods’ recent earnings revealed a robust performance in the first quarter of fiscal 2025, reflecting the effectiveness of its long-term strategies and operational improvements.
  • The company reported a 4.5% increase in comparable store sales, marking the fifth consecutive quarter of such growth, and achieved a consolidated sales increase of 5.2% to $3.17 billion.
  • These results were underpinned by a rise in both average ticket value and transaction volume, demonstrating strong consumer demand and engagement with DICK’S product offerings.

Elastic Ramps Up Cybersecurity Assault with Bold Security Platform Expansion!

By Baptista Research

  • Elastic N.V. reported a strong fourth quarter, capping off fiscal 2025 with solid growth metrics and notable strategic advancements.
  • The company’s revenue grew by 16% year-over-year, with Elastic Cloud revenue increasing by 23%, reflecting sustained demand for their solutions.
  • Elastic’s efforts to penetrate both the enterprise and mid-market segments have borne fruit, as evidenced by the net increase in large customers—those spending over $1 million annually—by approximately 45 this year.

C3.ai Strikes Gold with Powerhouse Partnerships—Is Big Tech Its Secret Weapon?

By Baptista Research

  • C3.ai has demonstrated dynamic progress and significant strides in its fiscal year ending April 30, 2025, highlighted by impressive growth metrics and strategic advancements.
  • The company reported a 25% year-over year revenue increase, reaching $389.1 million, marking three consecutive years of accelerating revenue growth.
  • This upward trajectory underscores the company’s effective strategies in the expansive Enterprise AI market.

Interparfums Unveils Bold Luxury Push with New Premium Brand Additions!

By Baptista Research

  • Interparfums reported a 5% increase in net sales for the first quarter of 2025, with a 7% growth on a like-for-like basis.
  • These results were driven by strong performances from brands such as Coach, Jimmy Choo, and Donna Karan, as well as newer entries like Lacoste and Cavalli.
  • The company’s diverse product launches and agile supply chain supported its ability to adapt rapidly to market demands, although some challenges remain due to a shifting global landscape.

Dell Technologies: AI Server Integration & Backlog Growth As A Pivotal Growth Lever!

By Baptista Research

  • Dell Technologies Inc.’s fiscal year 2026 first quarter financial results provide a mixed but generally positive view of the company’s current performance and future prospects.
  • The company reported revenue of $23.4 billion, a growth of 5% year-over-year.
  • This increase was driven by robust performance across its core markets, particularly in Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG), each growing by 8%.

GEN Digital Is Tapping Into Telecom & Employers—Can This Be The Biggest Driver Of Its Future Growth?

By Baptista Research

  • Gen Digital’s latest financial results and strategic developments present a balanced picture of growth and ongoing transformation within the company.
  • During the fiscal year 2025, Gen Digital demonstrated solid financial performance, highlighted by a record revenue of nearly $4 billion, a 4% year-over-year increase, and a non GAAP operating margin of 58.4%.
  • This growth was driven by strong demand across Gen’s core cyber safety offerings, including security, privacy, and identity theft protection solutions.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Sun Pharmaceutical Industries, Canara Bank and more

By | Daily Briefs, India

In today’s briefing:

  • Sun Pharmaceutical (SUNP IN): Timely Succession Plan to Augur Well for Next-Level of Growth
  • Relative Value Roundup: Performance Recap of Financial Pair Trades


Sun Pharmaceutical (SUNP IN): Timely Succession Plan to Augur Well for Next-Level of Growth

By Tina Banerjee

  • Sun Pharmaceutical Industries (SUNP IN) is appointing Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business reporting to him.
  • In another development, Richard Ascroft will be joining as CEO – North America, succeeding Abhay Gandhi. Aalok Shanghvi has been additionally entrusted with the responsibility for the North America business.
  • Succession plan and management rejig come at a time when SPIL is at an inflection point, with its India business being on a strong foothold and specialty business gaining traction.

Relative Value Roundup: Performance Recap of Financial Pair Trades

By Gaudenz Schneider

  • Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities.
  • Highlight: Two pair trade opportunities in the Indian financial sector persist, with price ratios exceeding two standard deviations from their historical means.
  • Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: TSE Tokyo Price Index TOPIX, Azoom, Hino Motors Ltd, Mitsubishi Shokuhin and more

By | Daily Briefs, Japan

In today’s briefing:

  • One of the Clues to Know How Serious a Company Is About Shifting to Management that Creates Value
  • TOPIX Inclusions: Who Is Ready (Jun 2025)
  • Last Week in Event SPACE: Hino Motors, Hong Kong’s Peg, Zijin Mining, MINISO
  • (Mostly) Asia-Pac M&A: New World Res., Fuji Corp, TRYT, Shinsung Tongsang, Austal, Mitsu. Shokuhin


One of the Clues to Know How Serious a Company Is About Shifting to Management that Creates Value

By Aki Matsumoto

  • The driver of higher stock valuations is overseas investors, and engagement by overseas investors is likely to have a positive effect on return on capital and stock valuations.
  • In many aspects, companies seem to be unwilling to face shareholders. If they don’t confront shareholders and proceed with management reforms, they will not be able to implement serious initiatives.
  • It can be hypothesized that the behavior of prioritizing control over the AGM over engaging with shareholders provides a clue as to the seriousness of a company’s efforts.

TOPIX Inclusions: Who Is Ready (Jun 2025)

By Janaghan Jeyakumar, CFA

  • Quiddity’s “Who is Ready” series of insights aims to objectively identify names listed on the Tokyo Stock Exchange that are potential additions to the TOPIX Index in future.
  • GMO Financial Gate (4051 JP) and Azoom (3496 JP) have confirmed their moves to the Prime Market which would trigger TOPIX Inclusions for these names at the end of July.
  • Kitazato (368A JP) is expected to get listed in the Prime market in late-June and that name would also have a TOPIX Inclusion at the end of July. 

Last Week in Event SPACE: Hino Motors, Hong Kong’s Peg, Zijin Mining, MINISO

By David Blennerhassett

  • Is Hino (7205 JP) a short or a long at ¥366/share? Suggest short, but also selling more as the stock goes up, and buying back the short on big dips.
  • A Bloomberg op-ed piece concludes it is time to move on from “from an archaic currency regime“. That conclusion on the Hong Kong peg appears presumptuous. And uninformed.
  • A spin-off makes sense as Zijin (2899 HK) capitalises on the upward cycle in gold prices. However,  Zijin is trading at a single-digit NAV discount. Before any holding company discount.

(Mostly) Asia-Pac M&A: New World Res., Fuji Corp, TRYT, Shinsung Tongsang, Austal, Mitsu. Shokuhin

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 15 Jun 2025

By | Private Markets, Smartkarma Newswire

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. Air India’s Boeing 787 Dreamliner Crash Raises Safety Concerns
    The fatal crash of Air India’s London-bound Boeing 787 Dreamliner has brought attention to the US company’s track record on safety, highlighting the importance of trust and oversight in aviation.

  2. Vietnam-based VC Fund Managers Raising Successor Funds
    VinaCapital, ThinkZone Ventures, and Do Ventures are facing challenges in fundraising due to the lack of meaningful exits in Vietnam, emphasizing the importance of track records in private markets.
  3. Southeast Asia Tech M&A Trends
    M&A activity in Southeast Asia saw a decline in deal volume in 2024, with only 41 tech M&A deals recorded in the first five months of 2025, indicating a slow market stabilization.
  4. Insights from Industry Leaders
    Top executives from Schroders Capital, InnoVision Capital, White Whale Group, SUSI Partners, SPIL Ventures, and KFin Technologies shared their perspectives on market trends and investment strategies in Asia.
  5. Grab’s Acquisition Plans
    Grab plans to raise $1.25 billion in convertible senior notes for potential acquisitions, signaling its intentions for big acquisitions in the near future.
  6. Southeast Asia Startup Acquisitions
    Lifull Connect acquires proptech firm Lamudi’s operations in Indonesia and the Philippines, while DailyCo is finalizing the acquisition of Yummy Corp through a share swap deal.
  7. Funding News
    FlexiLoans.com raises $43.9 million in its Series C funding round, while Atome secures a $75 million asset-backed facility from Lending Ark to support its expansion in the region.
  8. LP-GP Updates
    CapitaLand Investment secures additional commitments for its lodging fund, Ares Management raises $2.4 billion for its fund dedicated to data centers in Japan, and Artisan Partners liquidates its China-focused investment portfolio.
  9. Real Estate Investments
    The Wealth Company Asset Management launches Bharat Bhoomi Fund in India, marking its entry into the real estate segment under the Bharat Value Fund platform.
  10. Market Analyses
    Chinese AI companies prepare for IPOs, India’s single-specialty hospital chains attract private equity investments, highlighting the growing interest in focused healthcare models.

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma